DA - Medicina - Hematología - Artículos de revista : [163]

Subscribe to this collection to receive daily e-mail notification of new additions RSS Feed RSS Feed RSS Feed
Collection's Items (Sorted by Submit Date in Descending order): 41 to 60 of 163
Issue DateTitleTypeAuthor(s)
2004Acquired potential N-glycosylation sites within the tumor-specific immunoglobulin heavy chains of B-cell malignanciesArticuloZabalegui, N. (Natalia); Lopez-Diaz-de-Cerio, A. (Ascensión); Inoges, S. (Susana), et al
2004Variations in “rescuability” of immunoglobulin molecules from different forms of human lymphoma: implications for anti-idiotype vaccine developmentArticuloRodriguez-Calvillo, M. (Mercedes); Inoges, S. (Susana); Lopez-Diaz-de-Cerio, A. (Ascensión), et al
2004Past, present and future of anti-idiotype vaccinationArticuloRodriguez-Calvillo, M. (Mercedes); Inoges, S. (Susana); Lopez-Diaz-de-Cerio, A. (Ascensión), et al
2003RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elementsArticuloPuig-Kröger, A. (Amaya); Sanchez-Elsner, T. (Tilman); Ruiz, N. (Natividad), et al
2004The role of idiotype vaccines in the treatment of human B-cell malignanciesArticuloBendandi, M. (Maurizio)
2005Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas.ArticuloMazzolini, G. (Guillermo); Alfaro, C. (Carlos); Sangro, B. (Bruno), et al
2006Immunogenic cell death and cross-priming are reaching the clinical immunotherapy arenaArticuloMelero, I. (Ignacio); Arina, A. (Ainhoa); Murillo, O. (Oihana), et al
2006Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma.ArticuloInoges, S. (Susana); Rodriguez-Calvillo, M. (Mercedes); Zabalegui, N. (Natalia), et al
2006Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation.ArticuloBendandi, M. (Maurizio); Rodriguez-Calvillo, M. (Mercedes); Inoges, S. (Susana), et al
2006Clinical benefit of idiotype vaccines: too many trials for a clever demonstration?ArticuloBendandi, M. (Maurizio)
2006The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseasesArticuloAlfaro, C. (Carlos); Murillo, O. (Oihana); Tirapu, I. (Íñigo), et al
2007Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions.ArticuloRedondo, P. (Pedro); Olmo-López, J. (Julio) del; Lopez-Diaz-de-Cerio, A. (Ascensión), et al
2007Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor.ArticuloRadcliffe, C.M. (Catherine M.); Arnold, J.N. (J.N.); Suter, D.M. (David M.), et al
2007Anti-idiotype antibodies in cancer treatmentArticuloLopez-Diaz-de-Cerio, A. (Ascensión); Zabalegui, N. (Natalia); Rodriguez-Calvillo, M. (Mercedes), et al
2007Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer.ArticuloArina, A. (Ainhoa); Murillo, O. (Oihana); Dubrot, J. (Juan), et al
2008IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosisArticuloMartinez-Forero, I. (Iván); Garcia-Muñoz, R. (R.); Martinez-Pasamar, S. (Sara), et al
2009Prolonged idiotypic vaccination against follicular lymphomaArticuloInoges, S. (Susana); Lopez-Diaz-de-Cerio, A. (Ascensión); Zabalegui, N. (Natalia), et al
2009Idiotype vaccines for lymphoma: proof-of-principles and clinical trial failuresArticuloBendandi, M. (Maurizio)
2010Idiotype vaccines for human B-cell malignanciesArticuloInoges, S. (Susana); Cerio, A. (A.L.) de; Soria, E. (Elena), et al
2010Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphomaArticuloBendandi, M. (Maurizio); Marillonnet, S. (S.); Kandzia, R. (R.), et al
Collection's Items (Sorted by Submit Date in Descending order): 41 to 60 of 163